Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Blood Cancer Journal|December 13, 2018
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcomeAshley R Paquin, Shaji K Kumar, Francis K Buadi, et al.
Blood|March 28, 2009
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasonePrashant Kapoor, Shaji Kumar, Rafael Fonseca, et al.
Leukemia|February 22, 2019
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myelomaGaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, et al.
American Journal of Hematology|March 18, 2017
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosisNidhi Tandon, Surbhi Sidana, Morie A Gertz, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 13, 2017
Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosisNidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
American Journal of Hematology|August 9, 2016
Outcomes of patients with renal monoclonal immunoglobulin deposition diseaseTaxiarchis V Kourelis, Samih H Nasr, Angela Dispenzieri, et al.
American Journal of Hematology|October 26, 2017
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myelomaArjun Lakshman, Preet Paul Singh, S Vincent Rajkumar, et al.
Bone Marrow Transplantation|December 23, 2017
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosisSurbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Blood|January 7, 2006
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationAngela Dispenzieri, Martha Q Lacy, Jerry A Katzmann, et al.
Pageof 10